![Laura Hamill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Hamill
Director/Board Member at
BB BIOTECH AG
Net worth: 2 M $ as of 2026-05-30
Profile
Laura J.
Hamill is the founder of Hamill Advisory Group LLC, founded in 2019.
Current jobs include Director at BB Biotech AG since 2022, Director at Scilex Pharmaceuticals, Inc., Director at Unchained Labs LLC since 2022, Independent Director at Jazz Pharmaceuticals Plc since 2024, Director at Fate Therapeutics, Inc. since 2026, and Member at Women Business Leaders of the US Health Care Industry Fnd.
Former jobs include Independent Director at Acceleron Pharma, Inc. from 2020 to 2021, Independent Director at AnaptysBio, Inc. from 2019 to 2023, Independent Director at Scilex, Inc. in 2022, Independent Director at Pardes Biosciences, Inc. from 2021 to 2023, Independent Director at Scilex Holding Co. from 2022 to 2023, Independent Director at Y-mAbs Therapeutics, Inc. from 2020 to 2025, Executive VP-Worldwide Commercial Operations at Gilead Sciences, Inc. from 2018 to 2019, and Senior Vice President-US Commercial Operations at Amgen, Inc. from 2002 to 2018.
Education includes undergraduate studies at the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-08-07 | 6,933 ( 0.01% ) | 2 M $ | 2026-05-30 |
Laura Hamill active positions
| Companies | Position | Start |
|---|---|---|
| BB BIOTECH AG | Director/Board Member | 2022-03-16 |
| JAZZ PHARMACEUTICALS PLC | Director/Board Member | 2024-07-24 |
| FATE THERAPEUTICS, INC. | Director/Board Member | 2026-06-11 |
Women Business Leaders of the US Health Care Industry Fnd | Corporate Officer/Principal | - |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Director/Board Member | 2022-02-08 |
Scilex Pharmaceuticals, Inc.
 Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Director/Board Member | - |
Former positions of Laura Hamill
| Companies | Position | End |
|---|---|---|
| YMAS THER | Director/Board Member | 2025-09-15 |
| SCILEX HOLDING COMPANY | Director/Board Member | 2023-09-20 |
| PARDES BIOSCIENCES, INC. | Director/Board Member | 2023-08-29 |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Laura Hamill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
BB Biotech AG
 BB Biotech AG Financial ConglomeratesFinance Provides investment services for biotechnology sector | Finance |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Women Business Leaders of the US Health Care Industry Fnd | |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Unchained Labs
Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
Hamill Advisory Group LLC |
- Stock Market
- Insiders
- Laura Hamill
